Stockscreener 앱 받기
58.37
0.99%
0.57
시간 외 거래:
58.17
-0.20
-0.34%
전일 마감가:
$57.80
열려 있는:
$57.84
하루 거래량:
3.27M
Relative Volume:
0.92
시가총액:
$25.87B
수익:
$2.44B
순이익/손실:
$1.36B
주가수익비율:
30.57
EPS:
1.9093
순현금흐름:
$574.14M
1주 성능:
+4.64%
1개월 성능:
+6.40%
6개월 성능:
+44.98%
1년 성능:
+64.38%
1일 변동 폭
$57.58
$58.55
1주일 범위
$55.62
$58.55
52주 변동 폭
$34.08
$58.55
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
58.37 | 25.62B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
498.43 | 132.55B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
662.88 | 70.90B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
915.30 | 57.21B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
323.50 | 42.94B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.77 | 40.49B | 742.00K | -1.37B | -1.07B | -7.0731 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | UBS | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Y Intercept Hong Kong Ltd Grows Stake in Royalty Pharma PLC $RPRX - MarketBeat
Swedbank AB Sells 355,450 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma stock hits all-time high at 58.02 USD - Investing.com
Royalty Pharma stock hits all-time high at 58.02 USD By Investing.com - Investing.com India
Royalty Pharma plc (RPRX) Stock Analysis: Navigating the Biotech Sector with Robust Revenue Growth - DirectorsTalk Interviews
Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Fideuram Intesa Sanpaolo Private Banking S.P.A. Has $439,000 Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Moran Wealth Management LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (RPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ETFs Investing in Royalty Pharma Plc Class A Stocks - TradingView
USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Pictet Asset Management Holding SA Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,652,000.00 in Stock - MarketBeat
[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan
Royalty Pharma (RPRX) EVP Hite sells 130,000 shares in 10b5-1 trades - Stock Titan
Royalty Pharma plc (RPRX) insider Marshall Urist reports sales totaling ~$1.95M - Stock Titan
Form 144 Royalty Pharma PLC For: 1 July By Investing.com - Investing.com South Africa
[144] Royalty Pharma plc SEC Filing - Stock Titan
Royalty Pharma (RPRX) Shares Rally Following Earnings Report That Beat EstimatesTech Earnings Analysis - dars.gov.et
Form 4 Royalty Pharma Plc For: 30 June By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) director gets equity grant in lieu of cash - Stock Titan
Hsbc Holdings PLC Cuts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Joins Key Russell Indices, Is The Stock Fully Priced? - Sahm
Royalty Pharma (NASDAQ:RPRX) Hits New 12-Month HighTime to Buy? - MarketBeat
Royalty Pharma stock hits all-time high at 56.57 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits all-time high at 56.57 USD - Investing.com
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat - Insider Monkey
Royalty Pharma (RPRX) Stock Analysis: Evaluating Its 5.37% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Rockefeller Capital Management L.P. Purchases 81,747 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Does Royalty Pharma’s (RPRX) Index Upgrade Signal Deeper Defensive Strength In Its Business Model? - simplywall.st
Royalty Pharma plc(NasdaqGS: RPRX) added to Russell 1000 Defensive Index - marketscreener.com
Enterprise value to revenue forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Trading Systems Reacting to (RPRX) Volatility - Stock Traders Daily
Royalty Pharma PLC $RPRX Shares Sold by Goodman Advisory Group LLC - MarketBeat
Enterprise value to EBITDA forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Enterprise value to EBIT forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Price to earnings forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Enterprise value to EBITDA forward of Royalty Pharma Plc Class A – SWB:RPD - TradingView
Price to book forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Price to sales forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Enterprise value to revenue forward of Royalty Pharma Plc Class A – SWB:RPD - TradingView
Price to sales forward of Royalty Pharma Plc Class A – SWB:RPD - TradingView
Price to earnings forward of Royalty Pharma Plc Class A – SWB:RPD - TradingView
Barton Investment Management Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Insider Sell Alert: Marshall Urist Sells Shares of Royalty Pharm - GuruFocus
Form 4 Royalty Pharma Plc For: 25 June By Investing.com - Investing.com Nigeria
Royalty Pharma EVP Hite sells $8.16m in shares - Investing.com UK
Royalty Pharma EVP Hite sells $8.16m in shares By Investing.com - Investing.com Australia
Royalty Pharma (NASDAQ:RPRX) EVP Sells 9,098 Shares - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
3.27%
자본화:
|
볼륨(24시간):